References
- Cohen, M. H.; Johnson, J. R.; Pazdur, R. Food and Drug Administration Drug Approval Summary: Temozolomide plus Radiation Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme. Clin. Cancer Res. 2005, 11, 6767–6771. DOI: 10.1158/1078-0432.CCR-05-0722
- Stupp, R.; Gander, M.; Leyvraz, S.; Newlands, E. Current and Future Developments in the Use of Temozolomide for the Treatment of Brain Tumours. Lancet. Oncol. 2001, 2, 552–560. https://doi.org/10.1016/S1470-2045(01)00489-2
- Quirbt, I.; Verma, S.; Petrella, T.; Bak, K.; Charette, M. Members of the Melanoma Disease Site Group of Cancer Care Ontario’s Program. Temozolomide for the Treatment of Metastatic Melanoma. Curr. Oncol 2007, 14, 27–31.
- Newlands, E. S.; Stevens, M. F. G.; Wedge, S. R.; Wheelhouse, R. T.; Brock, C. Temozolomide: A Review of Its Discovery, Chemical Properties, Pre-Clinical Development and Clinical Trials. Cancer Treat. Rev. 1997, 23, 35–61. https://doi.org/10.1016/S0305-7372(97)90019-0
- Diez, B. D.; Statkevich, P.; Zhu, Y.; Abutarif, M. A.; Xuan, F.; Kantesaria, B.; Cutler, D.; Cantillon, M.; Schwarz, M.; Pallotta, M. G.; et al. Evaluation of the Exposure Equivalence of Oral versus Intravenous Temozolomide. Cancer Chemother. Pharmacol. 2010, 65, 727–734.https://doi.org/10.1007/s00280-009-1078-6
- Kim, H.; Likhari, P.; Parker, D.; Statkevich, P.; Marco, A.; Lin, C.-C.; Nomeir, A. A. High-Performance Liquid Chromatographic Analysis and Stability of anti-Tumor Agent Temozolomide in Human Plasma. J. Pharm. Biomed. Anal. 2001, 24, 461–468. https://doi.org/10.1016/S0731-7085(00)00466-0
- Reyderman, L.; Statkevich, P.; Thonoor, C. M.; Patrick, J.; Batra, V. K.; Wirth, M. Disposition and Pharmacokinetics of Temozolomide in Rat. Xenobiotica 2004, 34, 487–500. https://doi.org/10.1080/00498250410001685737
- Shen, F.; Decosterd, L. A.; Gander, M.; Leyvraz, S.; Biollaz, J.; Lejeune, F. Determination of Temozolomide in Human Plasma and Urine by High-Performance Liquid Chromatography after Solid-Phase Extraction. J. Chromatogr. B: Biomed. Sci. Appl. 1995, 667, 291–300. https://doi.org/10.1016/0378-4347(95)00040-P
- Gilant, E.; Kaza, M.; Szlagowska, A.; Serafin-Byczak, K.; Rudzki, P. J. Validated HPLC Method for Determination of Temozolomide in Human Plasma. Acta Pol. Pharm. 2012, 69, 1347–1355.
- Goldwirt, L.; Zahr, N.; Farinotti, R.; Fernandez, C. Development of a New UPLC‐MSMS Method for the Determination of Temozolomide in Mice: Application to Plasma Pharmacokinetics and Brain Distribution Study. Biomed. Chromatogr. 2013, 27, 889–893. https://doi.org/10.1002/bmc.2877
- Peer, C. J.; Ronner, L.; Rodgers, L.; McCully, C. M. L.; Warren, K. E.; Figg, W. D. Quantification of Temozolomide in Nonhuman Primate Fluids by Isocratic Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry to Study Brain Tissue Penetration following Intranasal or Intravenous Delivery. Separations 2016, 3, 4. https://doi.org/10.3390/chromatography3010004
- Andrási, M.; Törzsök, B.; Klekner, Á.; Gáspár, A. Determination of Temozolomide in Serum and Brain Tumor with Micellar Electrokinetic Capillary Chromatography. J. Chromatogr. B 2011, 879, 2229–2233. https://doi.org/10.1016/j.jchromb.2011.06.005
- Jain, D.; Athawale, R.; Bajaj, A.; Shrikhande, S. Double-Salting out Assisted Liquid–Liquid Extraction (SALLE) HPLC Method for Estimation of Temozolomide from Biological Samples. J. Chromatogr. B 2014, 970, 86–94. https://doi.org/10.1016/j.jchromb.2014.02.031
- Pallerla, S.; Prabhakar, B. Bioanalytical Method Development and Validation of Temozolomide in Rat Plasma Using RP-HPLC Method. Int. J. Pharm. Sci. Res. 2016, 7, 1298–1301. DOI: 10.13040/IJPSR.0975-8232.7(3).1298-01
- Ghosh, C. Green Bioanalysis: Some Innovative Ideas towards Green Analytical Techniques. Bioanalysis 2012, 4, 1377–1391. https://doi.org/10.4155/bio.12.31
- United States Food and Drug Administration. Draft Guidance for Industry: Bioanalytical Method Validation, 2001. http://www.bioagilytix.com/wp-content/uploads/2016/02/FDA-Bioanalytical-Method-Validation-Draft-Guidance-2013.pdf (accessed Jun 10, 2018).